Experimental modeling of mandibular defect and analysis of the functional efficiency of the jaw exoskeleton

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Modeling of jaw bone defects after bisphosphonate administration is presently an urgent task of oral surgery. Methods for virtual modeling of pathological processes and ways for their elimination are becoming increasingly popular in experimental studies. However, biomedical research with experimental animals, which is strictly regulated by law, does not lose its relevance. The choice of a model for our study has been based on the assumption that bisphosphonate-associated osteonecrosis and jaw defect in experimental animals are identical to human clinical presentations. In addition, this study considers the development of devices for correcting biomechanical problems and positioning the jaw bone fragments. Simulated subtotal mandibular defects are accompanied by restricted mouth opening, malnutrition and, as a result, inhibited habitual functional activity in the experimental animals. This has served as a guide for incorporating the simultaneous fixation of fragments with a multifunctional device, such as with the mandibular exoskeleton, into the protocol of surgical intervention. Positive changes in the early postoperative period have been characterized by restoration of the biomechanical balance of the dentition. The findings provide evidence that it is necessary to modernize the device and to test the exoskeleton in patients with subtotal mandibular defects.

Full Text

Restricted Access

About the authors

M. V. Loktionova

I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Author for correspondence.
Email: Marinavrach@mail.ru
ORCID iD: 0000-0003-3555-2035

Candidate of Medical Sciences

Russian Federation, Moscow

I. V. Gabbasova

Stavropol State Medical University, Ministry of Health of Russia

Email: Marinavrach@mail.ru
ORCID iD: 0000-0003-3850-4274
Russian Federation, Stavropol

V. A. Sletova

Stavropol State Medical University, Ministry of Health of Russia

Email: Marinavrach@mail.ru
Russian Federation, Stavropol

H. M. Magomedova

Dagestan State Medical University, Ministry of Health of Russia

Email: Marinavrach@mail.ru
Russian Federation, Makhachkala

E. M. Uzdenov

Karachay-Cherkessia Medical Academy, Ministry of Health of Russia

Email: Marinavrach@mail.ru
Russian Federation, Cherkessk

V. S. Zakharyan

Kuban State Medical University, Ministry of Health of Russia

Email: Marinavrach@mail.ru
Russian Federation, Krasnodar

A. A. Sletov

Stavropol State Medical University, Ministry of Health of Russia; Stavropol Territory Clinical Hospital

Email: Marinavrach@mail.ru
ORCID iD: 0000-0001-5183-9330

Doctor of Medical Sciences, Professor

Russian Federation, Stavropol; Stavropol

O. I. Admakin

I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: Marinavrach@mail.ru
ORCID iD: 0000-0002-5626-2961

Doctor of Medical Sciences, Professor

Russian Federation, Moscow

References

  1. Basin E.M. Toxic phosphoric necrosis of the facial skull. Abstract of the dissertation for the degree of Doctor of Medical Sciences. М.: I.M. Sechenov First Moscow State Medical University, 2017; р. 36 (in Russ.).
  2. Berezov T.T., Makletsova M.G., Siatkin S.P. et al. A role of polyamine metabolism in the functional activity of the normal and pathological brain. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2013; 113 (7): 65–70 (in Russ.).
  3. Biochemistry. Textbook. Ed. by E.S. Severin. 2nd ed. M.: GEOTAR-MED, 2004; pр. 516–7 (in Russ.).
  4. Garaeva S.N., Redkozubova G.V. Postolati G.V. Amino acids in a living organism. Kishinev, 2009; pp. 68–85 (in Russ.).
  5. Litvitsky P.F., Mal'tseva L.D. Protein, Amino Acids and Nucleic Acids Metabolism Disorders. Current Pediatrics. 2015; 14 (1): 95–107 (in Russ.).
  6. Mikhailov V.V. Fundamentals of pathological physiology. A guide for doctors. M.: Meditsina, 2001; pp. 254–665 (in Russ.).
  7. Petrosyan A.L., Kutukova S.I., Chefu S.G. et al. Sulodexide as a choice of prevention of bisphosphonate osteonecrosis. Smolensk Medical Almanac. 2018; 4: 118–20 (in Russ.).
  8. Pauling L., Pauling P. Chemistry. М.: Mir, 1978; p. 389 (in Russ.).
  9. Manual of general human pathology. Textbook. Ed. by N.K. Khitrov, D.S. Sarkisov, M.A. Paltsev. M.: Meditsina, 1999; p. 213 (in Russ.).
  10. Ebzeev A.K. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) in cancer patients. Kazan Medical Journal. 2020; 101 (2): 226–31 (in Russ.). doi: 10.17816/KMJ2020-226
  11. Dunford J.E., Thompson K., Coxon F.P. et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonate. J Pharmacol Exp Ther. 2001; 296 (2): 235–42.
  12. Lee S.-H., Choi S.-Y., Bae M.-S. et al. Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment. Maxillofac Plast Reconstr Surg. 2021; 43 (1): 24. doi: 10.1186/s40902-021-00310-w
  13. Schaffer S., Ha Won Kim. Effects and Mechanisms of Taurine as a Therapeutic Agent. Biomol Ther (Seoul). 2018; 26 (3): 225–41. doi: 10.4062/biomolther.2017.251
  14. Soma T., Iwasaki R., Sato Y. et al. Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics. Sci Rep. 2022; 12 (1): 19. doi: 10.1038/s41598-021-03966-6

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies